Rx direct-to-consumer ads attracting FTC notice, commission attorney tells DIA.
Rx DIRECT-TO-CONSUMER ADS ATTRACTING FTC NOTICE, Federal Trade Commission Attorney Susan Cohn advised a Drug Information Association meeting on pharmaceutical marketing and promotion March 2 in New York City. "Now that we're seeing an increase in direct-to-consumer advertising, the FTC is watching the direct-to-consumer advertising of prescription drugs," Cohn said. "That's not to say that we've taken any action in the area, or that we're finding a lot to be concerned about, but it is an area that we're watching."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth